BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11153979)

  • 1. Osteonecrosis of the femoral head after allogeneic bone marrow transplantation.
    Torii Y; Hasegawa Y; Kubo T; Kodera Y; Minami S; Morishita Y; Yamada Y; Iwata H
    Clin Orthop Relat Res; 2001 Jan; (382):124-32. PubMed ID: 11153979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic bone marrow transplant in Belfast--an outcome overview of the first 25 years.
    Cargo CA; Yates E; Marley C; Piggott S; McMullin MF; Jones FG
    Ulster Med J; 2008 Sep; 77(3):185-90. PubMed ID: 18956801
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry.
    Bortin MM; Horowitz MM; Gale RP
    Nat Immun Cell Growth Regul; 1988; 7(5-6):334-50. PubMed ID: 3065641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors.
    Socié G; Sélimi F; Sedel L; Frija J; Devergie A; Esperou Bourdeau H; Ribaud P; Gluckman E
    Br J Haematol; 1994 Mar; 86(3):624-8. PubMed ID: 8043445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avascular necrosis in the femoral head secondary to bone marrow infarction in a patient with graft-versus-host disease after unrelated bone marrow transplantation.
    Mori A; Hashino S; Kobayashi S; Tanaka J; Yamamoto Y; Asaka M; Imamura M
    Ann Hematol; 2001 Apr; 80(4):238-42. PubMed ID: 11401092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cementless total hip arthroplasty for osteonecrosis of the femoral head after allogenic bone marrow transplantation.
    Petsatodis GE; Antonarakos PD; Christodoulou AG; Pappas LS; Pournaras JD
    J Arthroplasty; 2009 Apr; 24(3):414-20. PubMed ID: 18555655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of bone marrow cell dose in bone marrow transplantation.
    Paulin T
    Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late pulmonary impairment following allogeneic bone marrow transplantation.
    Beinert T; Düll T; Wolf K; Holler E; Vogelmeier C; Behr J; Kolb H
    Eur J Med Res; 1996 Apr; 1(7):343-8. PubMed ID: 9364037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
    Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M
    Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth in patients after allogeneic bone marrow transplant for hematological diseases in childhood.
    Cohen A; van Lint MT; Uderzo C; Rovelli A; Lavagetto A; Vitale V; Morchio A; Locasciulli A; Bacigalupo A; Romano C
    Bone Marrow Transplant; 1995 Mar; 15(3):343-8. PubMed ID: 7599557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
    Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
    Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
    Huang H; Lin M; Meng H
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation for the treatment of leukemia.
    Lu DP; Guo NL; Jin NR; Zheng H; Lu XJ; Shi Q; Shan FX; Jiang B; Tang H; Liu MY
    Chin Med J (Engl); 1990 Feb; 103(2):125-30. PubMed ID: 2118028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head.
    Shibatani M; Fujioka M; Arai Y; Takahashi K; Ueshima K; Okamoto M; Yoshimura N; Hirota Y; Fukushima W; Kubo T
    Acta Orthop; 2008 Oct; 79(5):631-6. PubMed ID: 18839369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.